PRJNA859129
RNA sequencing of primary or residual tumors +/- etomoxir
RNA sequencing of tumors from MMTV-rtTA;TetO-Her2/neu mice with primary tumors (on doxycycline), regressing tumors (8d following dox withdrawal), or residual tumors (21d following dox withdrawal). At each timepoint, mice were treated with vehicle or the Cpt1 inhibitor etomoxir.